Burry calls Birkenstock a full position at 30% discount to fair value

Birkenstock (BIRK) shares are being supported by Michael Burry adding to his position near ~$35.17, after Q3 2026 adjusted EPS rose 19% YoY to EUR 0.74 and management raised full-year adjusted EBITDA guidance to at least EUR 710M. However, the stock is still trading at a ~30.3% discount to a cited fair value of $45.84, and it fell 9.4% on Aug. 23 when a $1.0B follow-on equity offering (about +25.5M shares) coincided with a $500M buyback (about -12.8M shares), leaving net share dilution of ~12.7M. BIRK also faced an earnings overhang with a second consecutive quarterly GAAP EPS miss ($0.85 vs $0.86) and an ~11.8% decline since Aug. 13, making the next earnings print (consensus EPS $0.54) the key catalyst.

Analysis

The key signal is not Burry’s name recognition; it’s the mismatch between a relatively tight float and a company that now needs buyback execution to convert operating momentum into per-share upside. If repurchases lag the net share issuance, the next 1-2 quarters can still look cosmetically weak on EPS even if EBITDA is improving, which is exactly the setup that keeps short interest alive and makes the stock sensitive to one clean beat.

For AI, the cleaner loser is the capital-intensity/valuation complex rather than the category leader. NVDA remains the fundamental winner because demand is translating into cash flow now, while ORCL, PLTR, and NBIS are more exposed to any slowing in hyperscaler spend, higher discount rates, or doubts about when AI revenue catches up to capex; that is a 1-3 month multiple risk, not a same-day fundamental break. CAT is a second-order short only if AI data-center capex starts crowding out broader industrial spending, but that thesis needs macro confirmation.

Contrarian view: the market may be over-reading Burry as a macro oracle when this looks more like a barbell of idiosyncratic value and crowded-short opportunities. For BIRK, the thesis only works if management proves the buyback can offset dilution and the next print avoids another per-share miss; otherwise the stock can stay cheap for months despite strong branding. For the AI shorts, the reversal trigger is a fresh raise in guide from NVDA or hyperscaler capex, which would squeeze the most crowded names quickly.

Key Decisions for Investors

• Long NVDA vs short ORCL or PLTR for 1-3 months: best risk/reward is owning the profit pool leader against the most valuation-sensitive AI monetization names; thesis breaks if NVDA guide does not outperform or if ORCL/PLTR reaccelerate revenue without margin giveback.
• Avoid chasing BIRK after the bounce; only initiate a tactical long if the next quarterly EPS meets or exceeds the ~$0.54 consensus and management shows buyback pace can offset the new shares. Below the post-earnings bounce low, the dilution overhang likely dominates for another quarter.
• Use NBIS as the highest-beta short among the named AI names via puts or a small tactical short into strength; capital-market dependence makes it the most vulnerable if risk appetite fades. Cover if funding terms improve or if management outlines a clear path to self-funding.
• Treat CAT as a conditional short only if AI capex indicators roll over; otherwise the stock is more of a sentiment hedge than a clean expression. Falsify on continued hyperscaler capex strength or positive industrial order data.